603676.SH
卫信康
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 9.14
−2.04%Margins
Gross margin
61.5%
EBITDA margin
29.1%
EBIT margin
23.9%
Net margin
18.6%
FCF margin
11.8%
14.0%
Return on equity
11.1%
Return on assets
17.9%
Return on invested capital
0.61x
Asset turnover
CNY 223.0M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026